MedTrace Logo

The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement

NCT01375335 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2013-08-07

No results posted yet for this study

Summary

The use of dobutamine in postoperative hemodynamic treatment is widespread despite seemingly intact contraction of the heart. This study aims to elucidate the efficacy of low-dose dobutamine infusion in patients in the postoperative phase replacement of the aortic valve.

Conditions

Interventions

DRUG

Dobutamine

90 minutes of infusion 5 ug/kg/minute followed by isotonic saline for the same duration. The sequence of the above is randomized

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Erik Sloth, Professor · Department of Anaesthesia & Intensive Care, Århus Univerisity Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01375335 on ClinicalTrials.gov